Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways

NCT05124288 · clinicaltrials.gov ↗

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia, in Relapse

Interventions

OTHER: Observations on Relapsed AML Allogeneic Transplanted patients

Sponsor

Ciceri Fabio

Collaborators

[object Object]
[object Object]